Humana Stock News

Investors are worried about what a Trump administration means for hospital operators and vaccine makers, but are optimistic about the fate of Medicare Advantage plan providers.

Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA-focused companies. Despite headwinds, Humana's Q3 earnings showed resilience with adjusted EPS of $4.16 and upgraded individual MA membership growth by 40k members. Humana aims for a 3% margin by 2027, focusing on clinical excellence, efficient operations, and strategic ...

Super Micro joined the list after a 33% drop on Wednesday.

Humana Inc. (NYSE:HUM ) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President and CEO Susan Diamond - CFO George Renaudin - President, Insurance Conference Call Participants Justin Lake - Wolfe Research Ann Hynes - Mizuho Andrew Mok - Barclays Ben Hendrix - RBC Capital Markets Sarah James - Cantor Fitzgerald Joshua Raski...

Humana (NYSE:HUM), a for-profit American health insurance firm, reported a beat on the top and bottom lines for the third quarter and strengthened its full year profit guidance, sending its shares higher on Wednesday. Revenue for Q3 was $29.3 billion, topping estimates of $28.7 billion.

The health insurer still sees full-year adjusted per-share earnings of at least $16.

Humana beat Wall Street estimates for third-quarter profit on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2024 (3Q24) versus the quarter ended September 30, 2023 (3Q23) and for the nine months ended September 30, 2024 (YTD 2024) versus the nine months ended September 30, 2023 (YTD 2023) as noted in the tables below. Consolidate...